Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Clinical evolution

Clinical evolution

Randomised clinical trials have been the mainstay of pharmaceutical product development for decades, but will they be designed and carried out the same way in future? With trials tipped to get smaller and patient selection more complex as pharma’s blockbuster model is dismantled, interactive technologies, adaptive designs and new ways to recruit and monitor patients will come to the fore.

News from CPhI

India will stamp out "fly by night operators" in trial industry, says Gov

27-Nov-2012 - The Indian Government will stamp out “fly by night operators” in its clinical trials sector by plugging "loopholes" in the regulations.

Risk-based monitoring could simplify trial data QC, according to Annex Clinical

26-Nov-2012 - Risk-based monitoring means certain aspects of clinical trials can be quality checked using a segment of the data, according to Annex Clinical.

News from PCT

CRA turnover in China too high: PCT discussion

21-Nov-2012 - High CRA turnover in China often hinders trials, according to an Oxford University expert.

News in brief

Boehringer set to make E.coli for clinical trials

12-Nov-2012 - Molecular Partners has contracted Boehringer Ingelheim to produce a range of highly potent molecules for its clinical pipeline.

Report from PCT Europe

Is risk-based clinical trial monitoring too flexible for the regulators?

12-Nov-2012 - Risk-based monitoring for clinical trials was a hot topic at this year’s PCT Europe thanks to recent draft guidances from the FDA and the EMA.


Strategic deals fit with regulators' risk-based site monitoring

08-Nov-2012 - Risk-based site monitoring is easier under strategic partnerships than other relationship models according to Covance.


PCT Europe 2012: Managing risk, emerging markets and industry criticism

08-Nov-2012 - is in Hamburg,Germany this week to meet the CROs, sponsors and academics gathered at PCT Europe to discuss the future of partnerships in clinical trials.

News from CPhI

Aesica ramps up HPAPI capacity to meet industry demand

07-Nov-2012 - The technical challenge posed by potent APIs means drug industry demand for R&D-scale contract manufacturing is largely unmet, according to Aesica.

News in brief

Catalent aims to boost drug delivery through industry-academia partnership

18-Oct-2012 - Catalent has established a new institute in a bid to advance drug delivery by creating links between industry and academia.

Industry too afraid to include children in clinical trials, says expert

10-Oct-2012 - The pharma industry does not include children in clinical research for fear of mentally scarring them, according to

Icon and South Korean Government team up to drive clinical activity

04-Oct-2012 - Icon has forged an alliance with the South Korean Government in a bid to boost local trial activity.

Quintiles set to boost Scotland's "promising" clinical trials market

02-Oct-2012 - Quintiles has forged a deal with the Scottish Government which it says will boost clinical trial activity in the country.

WorldCare Clinical launches clinical trials review service at request of FDA

02-Oct-2012 - WorldCare Clinical has launched a blinded independent safety and efficacy review service to speed FDA approval of clinical trial data.


Open source paradigm could swipe biz from CROs: Beroe

27-Sep-2012 - Open source drug developers could swipe business from CROs in the drug discovery field, according to Beroe.

Clinical trials should involve the elderly more, say experts

19-Sep-2012 - Geriatric patients are left out of trials too often say experts who want researchers to 'open their minds' to the benefits of recruiting the elderly.

Improving Biopharma R&D efficiency a mixed blessing for CROs

06-Sep-2012 - Improving efficiency in biopharma research is a “mixed blessing” for contract research organisations (CROs), according to Wells Fargo.

Online drug accountability systems will replace paper, says Cenduit

04-Sep-2012 - Automated drug accountability systems are becoming “the norm” in clinical trials because they can improve compliance and cut working time drastically, according to Cenduit.

Is cloud computing hot air? Comprehend Systems shoots the breeze with OSP

23-Aug-2012 - Comprehend Systems recently made its data analytics, visualisations and reports software available from the cloud. CEO Rick Morrison spoke with about the firm’s reasoning, and why no rockets were...

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

21-Aug-2012 - The proposed changes to European clinical trial regulations accepted by the European Commission (EC) in July  will put Europe on an equal playing field, according to Clinipace’s Andrea Schiefer....

DaVita opens PI facility for kidney research

20-Aug-2012 - DaVita Clinical Research has opened a Phase I facility focussed on kidney research in a bid to meet a “growing demand” for renal trials.

Theorem and Gallus team up to help drugsmakers in emerging markets go State side

16-Aug-2012 - Theorem and Gallus say their new biologics manufacturing partnership is aimed at giving a “leg up” to drugsmakers in emerging markets looking to market products in the US.

Icon readies itself for translational medicine boom with Manchester expansion

14-Aug-2012 - Icon has boosted its Phase I translational medicine services in Manchester, UK, in preparation for what it believes will be a boom in the drug development area.

Exclusive interview

Cherry picking best functionalities is key, Bioclinca CEO tells OSP

13-Aug-2012 - BioClinica says the next eClinical revolution will be in programmes combining functionalities tailored to a client's specific needs.


Big Pharma looking to home care to bolster clinical activities:

09-Aug-2012 - will conduct home visits in clinical trials for three Big Pharma firms after forging an agreement with Nottingham University Hospitals Research and Innovation Department.

New pharma services from M&A and partnerships: round-up

07-Aug-2012 - presents the low down on new services forged by partnerships and M&A (mergers and acquisitions), including a molecular biology offering for Quotient, Onyx’s added purification and separation capabilities, and...

Key Industry Events


Access all events listing

Our events, Events from partners...